MEI Pharma (MEIP)

Add to Watchlists
Create an Alert
8.50 -0.15  -1.73% NASDAQ Apr 17, 3:17PM BATS Real time Currency in USD
View Full Chart
MEIP Price Chart
View All Events

MEIP Events

Date Type Description
Sep 10 Misc MEI Pharma Acquires Pwt143, a Highly Selective Pi3-kinase Delta Inhibitor
View All Performance Charts

MEIP Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). MEI Pharma is up 4.81% over the last year vs S&P 500 Total Return up 21.27%, Lannett Company up 211.2%, and NephroGenex up N/A.

Get Quote for

Portfolio Strategies Featuring MEIP

Did MEI Pharma make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

MEIP Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: June 30, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

MEI Pharma Inc is a development-stage oncology company engaged in the clinical development of novel small molecules for the treatment of cancer.

Recent Quotes

Symbol Price Chg Chg % Market Cap
MEIP 8.50 -0.15 -1.73% 182.71M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.